Trade Summary

1 week ago, Doraiswamy Vinayak, serving as Chief Scientific Officer at AtriCure, Inc. (ATRC), sold 6,000 shares at $38.88 per share, for a total transaction value of $233,280.00. Following this transaction, Doraiswamy Vinayak now holds 86,511 shares of ATRC.

This sale represents a 6.49% decrease in Doraiswamy Vinayak's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 30, 2026 at 4:57 PM ET, 2 days after the trade was made.

AtriCure, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.